Lithium Carbonate
Active substance: lithium carbonate
CAPSULE · LITHIUM CARBONATE 300 mg/1
United StatesActive
Marketing holder: Glenmark Pharmaceuticals Inc., USA
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- LITHIUM CARBONATE · 300 mg/1
Registration
- Registration number
- 68462-221
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 68462-221 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 68462-221 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 68462-221 · Verified 2026-10-09 · open in source